|
DMXL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1691000003149E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.21380000001259E-06 |
| Normal-vs-Stage2 |
8.430400E-02 |
| Normal-vs-Stage3 |
2.318200E-03 |
| Normal-vs-Stage4 |
2.675600E-01 |
| Stage1-vs-Stage2 |
3.003400E-01 |
| Stage1-vs-Stage3 |
9.551200E-01 |
| Stage1-vs-Stage4 |
5.172400E-01 |
| Stage2-vs-Stage3 |
3.942800E-01 |
| Stage2-vs-Stage4 |
9.348200E-01 |
| Stage3-vs-Stage4 |
5.832400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.28700000007798E-07 |
| Normal-vs-AfricanAmerican |
1.8398899999994E-05 |
| Normal-vs-Asian |
3.949400E-01 |
| Caucasian-vs-AfricanAmerican |
8.596600E-01 |
| Caucasian-vs-Asian |
4.881000E-01 |
| AfricanAmerican-vs-Asian |
4.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88519999999581E-06 |
| Normal-vs-Female |
1.79929999999384E-06 |
| Male-vs-Female |
4.537000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.764900E-04 |
| Normal-vs-Extreme_Weight |
1.72998999999896E-05 |
| Normal-vs-Obese |
3.578900E-04 |
| Normal-vs-Extreme_Obese |
1.391970E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.245600E-01 |
| Normal_Weight-vs-Obese |
7.180800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.116200E-01 |
| Extreme_Weight-vs-Obese |
7.159800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.947200E-01 |
| Obese-vs-Extreme_Obese |
6.115000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.802800E-04 |
| Normal-vs-Age(41-60Yrs) |
7.602300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.79080000010046E-08 |
| Normal-vs-Age(81-100Yrs) |
2.343400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.835600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.455200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.577800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.340000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.663200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.324400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69959999910085E-08 |
| Normal-VS-Type2 PRCC |
2.604200E-02 |
| Normal-VS-KIRP CIMP |
1.57330037886538E-10 |
| Normal-VS-Unclassified PRCC |
2.764900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.050640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.0970000000029E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.987400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.17620000001018E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.753200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.210270E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.279800E-03 |
| Normal-vs-N1 |
1.061170E-03 |
| Normal-vs-N2 |
3.571900E-04 |
| N0-vs-N1 |
5.460800E-01 |
| N0-vs-N2 |
3.077200E-01 |
| N1-vs-N2 |
3.357400E-01 |
|
|
